Grown Rogue International Inc. (GRUSF)
OTCMKTS
· Delayed Price · Currency is USD
0.4420
+0.0820 (22.78%)
Apr 24, 2025, 3:57 PM EDT
Grown Rogue International Revenue
In the year 2024, Grown Rogue International had annual revenue of $27.02M with 23.77% growth. Grown Rogue International had revenue of $5.65M in the quarter ending December 31, 2024, a decrease of -13.34%.
Revenue
27.02M
Revenue Growth
+36.04%
P/S Ratio
3.28
Revenue / Employee
n/a
Employees
n/a
Market Cap
88.49M
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
SS Innovations International | 20.65M |
Endo Inc. | 1.76B |
Veradigm | 588.02M |
Elite Pharmaceuticals | 70.00M |
Northwest Biotherapeutics | 1.38M |
Glass House Brands | 200.90M |
BioStem Technologies | 301.83M |
American Oncology Network | 1.76B |
Grown Rogue International News
- 2 months ago - Cannabis Stock Valuations Reflect No Expectation Of Federal Reform: Study - Benzinga
- 6 months ago - Grown Rogue Is Focused On Jersey, Yield, Cost And Culture - Seeking Alpha
- 10 months ago - CSE Bulletin: Reclassification - Grown Rogue International Inc. Common Shares (GRIN) - Newsfile Corp
- 1 year ago - Reasons To Be Cautiously Optimistic About Cannabis - Seeking Alpha
- 2 years ago - Where Is The Value In Cannabis Stocks? - Seeking Alpha
- 3 years ago - Grown Rogue Announces Leadership Changes - Business Wire
- 3 years ago - Grown Rogue Completes Acquisition of State-of-the-Art, 30,000 Sq Ft Indoor Facility from Acreage Holdings Inc. - Business Wire
- 3 years ago - Grown Rogue Reports First Quarter 2022 Results, aEBITDA of $1.0M - Business Wire